A putative mechanism for downregulation of the catalytic activity of the EGF receptor via direct contact between its kinase and C-terminal domains

Structure

Volumn 12, Issue 12, 2004, Pages 2265-2275

  Landau, Meytal ^a   Fleishman, Sarel J ^a   Ben Tal, Nir ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHOTRANSFERASE;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; THEORETICAL MODEL;

EID: 9944246020     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.str.2004.10.006     Document Type: Article

References (48)

1. Al-Lazikani B., Sheinerman F.B., Honig B. Combining multiple structure and sequence alignments to improve sequence detection and alignment. application to the SH2 domains of Janus kinases Proc. Natl. Acad. Sci. USA. 98:2001;14796-14801
2. Biswas R., Basu M., Sen-Majumdar A., Das M. Intrapeptide autophosphorylation of the epidermal growth factor receptor. regulation of kinase catalytic function by receptor dimerization Biochemistry. 24:1985;3795-3802
3. Boerner J.L., Danielsen A., Maihle N.J. Ligand-independent oncogenic signaling by the epidermal growth factor receptor. v-ErbB as a paradigm Exp. Cell Res. 284:2003;111-121
4. Burgess A.W., Cho H.S., Eigenbrot C., Ferguson K.M., Garrett T.P., Leahy D.J., Lemmon M.A., Sliwkowski M.X., Ward C.W., Yokoyama S. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. Mol. Cell. 12:2003;541-552
5. Cadena D.L., Chan C.L., Gill G.N. The intracellular tyrosine kinase domain of the epidermal growth factor receptor undergoes a conformational change upon autophosphorylation. J. Biol. Chem. 269:1994;260-265
6. Chang C.M., Shu H.K., Ravi L., Pelley R.J., Shu H., Kung H.J. A minor tyrosine phosphorylation site located within the CAIN domain plays a critical role in regulating tissue-specific transformation by erbB kinase. J. Virol. 69:1995;1172-1180
7. Chantry A. The kinase domain and membrane localization determine intracellular interactions between epidermal growth factor receptors. J. Biol. Chem. 270:1995;3068-3073
8. Chiara F., Bishayee S., Heldin C.H., Demoulin J.B. Autoinhibition of the platelet-derived growth factor beta-receptor tyrosine kinase by its C-terminal tail. J. Biol. Chem. 279:2004;19732-19738
9. Cho H.S., Mason K., Ramyar K.X., Stanley A.M., Gabelli S.B., Denney D.W. Jr., Leahy D.J. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature. 421:2003;756-760
10. Dancey J.E. Predictive factors for epidermal growth factor receptor inhibitors - The bull's-eye hits the arrow. Cancer Cell. 5:2004;411-415
11. Ferguson K.M., Berger M.B., Mendrola J.M., Cho H.S., Leahy D.J., Lemmon M.A. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Mol. Cell. 11:2003;507-517
12. Fleishman S.J., Schlessinger J., Ben-Tal N. A putative molecular-activation switch in the transmembrane domain of erbB2. Proc. Natl. Acad. Sci. USA. 99:2002;15937-15940
13. Fleishman S.J., Unger V.M., Yeager M., Ben-Tal N. A C-alpha model for the transmembrane alpha-helices of gap-junction intercellular channels. Mol. Cell. 15:2004;879-888. a
14. Fleishman S.J., Yifrach O., Ben-Tal N. An evolutionarily conserved network of amino acids mediates gating in voltage-dependent potassium channels. J. Mol. Biol. 340:2004;307-318. b
15. Frederick L., Wang X.-Y., Eley G., James C.D. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Res. 60:2000;1383-1387
16. Gadella T.W. Jr., Jovin T.M. Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation. J. Cell Biol. 129:1995;1543-1558
17. Gamett D.C., Tracy S.E., Robinson H.L. Differences in sequences encoding the carboxyl-terminal domain of the epidermal growth factor receptor correlate with differences in the disease potential of viral erbB genes. Proc. Natl. Acad. Sci. USA. 83:1986;6053-6057
18. Glaser F., Pupko T., Paz I., Bell R.E., Bechor-Shental D., Martz E., Ben-Tal N. ConSurf. identification of functional regions in proteins by surface-mapping of phylogenetic information Bioinformatics. 19:2003;163-164
19. Gotoh N., Tojo A., Hino M., Yazaki Y., Shibuya M. A highly conserved tyrosine residue at codon 845 within the kinase domain is not required for the transforming activity of human epidermal growth factor receptor. Biochem. Biophys. Res. Commun. 186:1992;768-774
20. Griffith J., Black J., Faerman C., Swenson L., Wynn M., Lu F., Lippke J., Saxena K. The structural basis for autoinhibition of FLT3 by the juxtamembrane domain. Mol. Cell. 13:2004;169-178
21. Huse M., Kuriyan J. The conformational plasticity of protein kinases. Cell. 109:2002;275-282
22. Jiang G., Hunter T. Receptor signaling. when dimerization is not enough Curr. Biol. 9:1999;R568-R571
23. Jones S., Thornton J.M. Principles of protein-protein interactions. Proc. Natl. Acad. Sci. USA. 93:1996;13-20
24. Jorissen R.N., Walker F., Pouliot N., Garrett T.P., Ward C.W., Burgess A.W. Epidermal growth factor receptor. mechanisms of activation and signalling Exp. Cell Res. 284:2003;31-53
25. Kraulis P.J. Molscript. a program to produce both detailed and schematic plots of protein structures J. Appl. Crystallogr. 24:1991;946-950
26. Massoglia S., Gray A., Dull T.J., Munemitsu S., Kun H.J., Schlessinger J., Ullrich A. Epidermal growth factor receptor cytoplasmic domain mutations trigger ligand-independent transformation. Mol. Cell. Biol. 10:1990;3048-3055
27. Merritt E.A., Bacon D.J. Raster3D photorealistic molecular graphics. Methods Enzymol. 277:1997;505-524
28. Moriki T., Maruyama H., Maruyama I.N. Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain. J. Mol. Biol. 311:2001;1011-1026
29. Nicholls A., Sharp K.A., Honig B. Protein folding and association. insights from the interfacial and thermodynamic properties of hydrocarbons Proteins. 11:1991;281-296
30. Noelle V., Tennagels N., Klein H.W. A single substitution of the insulin receptor kinase inhibits serine autophosphorylation in vitro. evidence for an interaction between the C-terminus and the activation loop Biochemistry. 39:2000;7170-7177
31. Ogiso H., Ishitani R., Nureki O., Fukai S., Yamanaka M., Kim J.H., Saito K., Sakamoto A., Inoue M., Shirouzu M., Yokoyama S. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell. 110:2002;775-787
32. Pelley R.J., Maihle N.J., Boerkoel C., Shu H.K., Carter T.H., Moscovici C., Kung H.J. Disease tropism of c-erbB. effects of carboxyl-terminal tyrosine and internal mutations on tissue-specific transformation Proc. Natl. Acad. Sci. USA. 86:1989;7164-7168
33. Pupko T., Bell R.E., Mayrose I., Glaser F., Ben-Tal N. Rate4Site. an algorithmic tool for the identification of functional regions in proteins by surface mapping of evolutionary determinants within their homologues Bioinformatics. 18:2002;S71-S77
34. Raines M.A., Maihle N.J., Moscovici C., Moscovici M.G., Kung H.J. Molecular characterization of three erbB transducing viruses generated during avian leukosis virus-induced erythroleukemia. extensive internal deletion near the kinase domain activates the fibrosarcoma- and hemangioma-inducing potentials of erbB J. Virol. 62:1988;2444-2452
35. Riedel H., Schlessinger J., Ullrich A. A chimeric, ligand-binding v-erbB/EGF receptor retains transforming potential. Science. 236:1987;197-200
36. Robinson H.L., Tracy S.E., Nair N., Taglienti-Sian C., Gamett D.C. Characterization of an angiosarcoma-inducing mutation in the erbB oncogene. Oncogene. 7:1992;2025-2030
37. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 103:2000;211-225
38. Schlessinger J. Signal transduction. autoinhibition control Science. 300:2003;750-752
39. Serrano L., Horovitz A., Avron B., Bycroft M., Fersht A.R. Estimating the contribution of engineered surface electrostatic interactions to protein stability by using double-mutant cycles. Biochemistry. 29:1990;9343-9352
40. Sheinerman F.B., Norel R., Honig B. Electrostatic aspects of protein-protein interactions. Curr. Opin. Struct. Biol. 10:2000;153-159
41. Shewchuk L.M., Hassell A.M., Ellis B., Holmes W.D., Davis R., Horne E.L., Kadwell S.H., McKee D.D., Moore J.T. Structure of the Tie2 RTK domain. self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail Structure. 8:2000;1105-1113
42. Stamos J., Sliwkowski M.X., Eigenbrot C. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J. Biol. Chem. 277:2002;46265-46272
43. Walker F., Kato A., Gonez L.J., Hibbs M.L., Pouliot N., Levitzki A., Burgess A.W. Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation. Mol. Cell. Biol. 18:1998;7192-7204
44. Wedegaertner P.B., Gill G.N. Effect of carboxyl terminal truncation on the tyrosine kinase activity of the epidermal growth factor receptor. Arch. Biochem. Biophys. 292:1992;273-280
45. Wood E.R., Truesdale A.T., McDonald O.B., Yuan D., Hassell A., Dickerson S.H., Ellis B., Pennisi C., Horne E., Lackey K., et al. A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib). relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells Cancer Res. 64:2004;6652-6659
46. Yarden Y., Schlessinger J. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry. 26:1987;1443-1451
47. Yarden Y., Sliwkowski M.X. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2:2001;127-137
48. Yu X., Sharma K.D., Takahashi T., Iwamoto R., Mekada E. Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling. Mol. Biol. Cell. 13:2002;2547-2557